跳至主要内容
临床试验/IRCT201702261853N13
IRCT201702261853N13已完成未知

The study of the effect of tadalafil in comparison with tamsulosin and placebo on the symptoms of double-J stent insertion in ureteral following by transureteral ureteroscopy and lithotripsy in men with ureteral stones

rology Research Centre, Guilan University of Medical Sciences0 个研究点目标入组 120 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 139 years(—)
性别
Male

入选标准

  • male with age = 18 years; negative U/C; unilateral DJ-stent insertion; testimonial endorsement
  • Exclusion criteria: any underlying disease specially cardiovascular nephrogenic; allergic; other urologic disease; acute urinary retention (AUR); diabetes mellitus (DM); urinary tract malignancy; chronic pelvic pain syndrome (CPPS); Lower Urinary Tract Symptoms (LUTS); bilateral stent; PSA>10 ng/ml or PSA=4-10 ng/ml with positive prostate biopsy for malignancy; recent Extracorporeal shock wave lithotripsy (ESWL); stent malposition; neurogenic bladder; kidney transplant; radiation or chemotherapy; long term treatment with a-blockers, anticholinergic, analgesic, Selective serotonin reuptake inhibitors (SSRIs), diuretics, calcium channel blockers (CCB), lithium; opium addiction; all conditions that urologist prefers to exclude patient.

排除标准

  • 未提供

研究者

发起方
rology Research Centre, Guilan University of Medical Sciences

相似试验